Arginine deiminase PEG20 inhibits growth of small cell lung cancers lacking expression of argininosuccinate synthetase.

Br J Cancer · 2012 · PMC3261683 · PMID 22134507

Europe PMC DOI

hedged sentence

0.2600

closest p · 5.2× alpha

0.2600

boldest claim

The sentences

moderately significantP =0.26not close (p > 0.1)

Further, continued dosing was observed to cause a moderately significant ( P =0.26) reduction in tumour volume relative to the short-course treatment, as assessed at termination of the short-treatment group at day 39.

also in 2,182 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.